Spotting on Wegovy: Should You Be Concerned?

Why the hormone link matters more than the drug itself

Semaglutide does not directly target the uterus or the reproductive system. The NHS medicines page for semaglutide does not list spotting or menstrual irregularity as a recognised side effect. So when women do notice spotting on Wegovy, the more plausible explanation is indirect: losing weight changes the body's hormonal balance, sometimes quite quickly.

Fat tissue is metabolically active. It produces and stores oestrogen. When body fat decreases, circulating oestrogen levels can shift, and the hypothalamic-pituitary-ovarian axis, which regulates the menstrual cycle, can take time to recalibrate. The result can be anything from a lighter period to breakthrough bleeding at unexpected points in the cycle. This is the same mechanism that explains why rapid weight loss from any cause, whether from dietary changes, bariatric surgery, or intensive exercise, can temporarily disrupt periods.

Women who have had irregular cycles for years because of obesity-related hormonal imbalance sometimes find their cycle actually becomes more regular on Wegovy. Others notice the opposite at first, particularly in the early months of treatment. Both responses are documented. The decision to continue treatment, adjust it, or investigate further is one your prescriber is best placed to make once they know your history.

If you are considering starting semaglutide and have an existing gynaecological condition, it is worth flagging this during your initial consultation, and if you are based outside the UK you can find guidance on wegovy acquisto online to understand how access works in other countries. You can read more about how the treatment process works on our Wegovy overview page.

The contraceptive pill and absorption — a practical point

There is a specific, practical consideration for women who use oral contraceptives alongside any GLP-1 medicine, including Wegovy. Semaglutide slows the rate at which the stomach empties, and this altered gastric motility can affect how consistently oral medications are absorbed.

NHS England's guidance on weight management injections recommends that women taking oral contraceptives discuss their contraception with their clinician when starting a GLP-1 medicine. For tirzepatide (Mounjaro), the guidance is more explicit, recommending an additional non-oral method during dose increases. For semaglutide, the evidence is less definitive, but the general principle of consistent pill absorption remains a valid concern worth raising. A transdermal method (patch or gel) removes the absorption variable entirely, and that is worth discussing with your GP or prescriber.

Inconsistent pill absorption can itself cause spotting, independent of weight loss. If you have recently started Wegovy and are also on the pill, this combination is a reasonable first place to look before assuming any other cause. More detail on how to access semaglutide safely and what a prescriber will review is on our guide to getting semaglutide in the UK.

The broader context of how Wegovy is priced and what the full cost of treatment covers is separate from these clinical questions, but worth understanding before you commit to any provider.

When spotting becomes something to take seriously

Most spotting that starts around the same time as Wegovy, and settles within a couple of months, is likely hormonal adjustment and nothing more. That said, there are presentations that should prompt medical review sooner rather than later:

Post-menopausal bleeding of any kind warrants a GP appointment promptly, this is not a Wegovy-specific rule, but a standing recommendation for all women, regardless of what medicines they are taking. Similarly, spotting accompanied by pelvic pain, an unusual discharge, or that becomes heavier rather than lighter over time needs investigation. Cervical causes, polyps, and fibroids are far more common than most people realise, and they are not related to weight-loss treatment; they simply need to be excluded.

The MHRA's Yellow Card scheme allows patients to report suspected side effects from any medicine, including Wegovy. If you believe a symptom is related to your treatment and it has not been documented before, reporting it contributes to the national post-market surveillance picture. That matters, because Wegovy still carries a Black Triangle designation, meaning it is under additional safety monitoring.

Some women choosing to stop Wegovy, whether because of side effects or after reaching their goal, ask separately about what happens to their cycle afterwards. Our page on coming off Wegovy covers the post-treatment period in more detail, including weight considerations. The question of whether weight regain follows stopping treatment is addressed on our page on weight and Wegovy, which is a related concern for many.

What a clinician will actually consider

If you raise spotting with a prescriber at any point during your Wegovy treatment, a thoughtful clinical review will take into account: how long you have been on treatment, whether a dose increase preceded the spotting, your current contraception method, your cycle history before starting, and any relevant gynaecological history. None of these data points can be read in isolation.

Semaglutide as a broader medicine class has been in clinical use long enough that the absence of spotting from the documented side-effect profile is meaningful, not an oversight. The NHS England guidance on weight management injections covers the contraception and HRT considerations that prescribers follow, and reading it gives a clear sense of the level of clinical thinking involved.

At nume, every order is reviewed by a GPhC-registered Independent Prescriber before anything is dispensed. Your consultation is read by a named clinician on the day you submit it, and our aftercare team is available seven days a week if questions come up after your treatment arrives. If spotting is one of those questions, that is exactly the conversation to have with us. If you would like to discuss your situation with our prescribers, you can start your free consultation here, or read more about how we work on our guide to getting Wegovy online. When your treatment is approved and dispatched, it arrives in plain packaging via DPD next working day, with a tracking notification so you always know when to expect it.